Osteonecrosis in protease inhibitor-treated patients

Orthopedics

Volumn 24, Issue 3, 2001, Pages 271-272

  Bonfanti, P ^a   Gabbuti, A ^a   Carradori, S ^a   Pusterla, L ^a   Parazzini, F ^a   Landonio, S ^a   Quirino, T ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; GANCICLOVIR; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFICACY; FEMUR HEAD NECROSIS; HIP PROSTHESIS; HIP SURGERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; PATHOGENESIS; REGISTRATION; RETINITIS;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INCIDENCE; MALE; OSTEONECROSIS; RISK ASSESSMENT;

EID: 0035079224     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Visceral and abdominal-fat accumulation associated with use of indinavir
2. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving IV protease inhibitors
3. Osteonecrosis and human immunodeficiency virus infection
4. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors
5. Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study
6. Epidemiology of thrombosis in HIV-infected individuals